Title Nitration of tyrosines in complement factor H domains alters its immunological activity and mediates a pathogenic role in age related macular degeneration

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of age-related macular degeneration-like pathology by complement factor H

  2015cited by this paper
• 2016 update of the PRIDE database and its related tools

  2015cited by this paper
• Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands

  2014influential reference
• Age-dependent changes in heparan sulfate in human Bruch's membrane: implications for age-related macular degeneration.

  2014influential reference
• Tyrosine nitration moderates the peptidase activity of human methionyl aminopeptidase 2.

  2013cited by this paper
• Protein tyrosine nitration: biochemical mechanisms and structural basis of functional effects.

  2013cited by this paper
• Mapping the differential distribution of proteoglycan core proteins in the adult human retina, choroid, and sclera.

  2012cited by this paper
• Age-related macular degeneration and the complement system.

  2012cited by this paper
• Tyrosine Modifications in Aging

  2012cited by this paper
• β₂-glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator.

  2011cited by this paper
• Complement factor H binds malondialdehyde epitopes and protects from oxidative stress

  2011influential reference
• The oil spill in ageing Bruch membrane

  2011cited by this paper
• Age-related accumulation of 3-nitrotyrosine and nitro-A2E in human Bruch's membrane.

  2010cited by this paper
• Impaired Binding of the Age-related Macular Degeneration-associated Complement Factor H 402H Allotype to Bruch's Membrane in Human Retina*

  2010cited by this paper
• C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progression.

  2010cited by this paper
• Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation.

  2009cited by this paper
• Interleukin-8 promoter polymorphism −251A/T is a risk factor for age-related macular degeneration

  2008cited by this paper
• Peroxynitrite Mediates Retinal Neurodegeneration by Inhibiting Nerve Growth Factor Survival Signaling in Experimental and Human Diabetes

  2008cited by this paper
• Translational Mini‐Review Series on Complement Factor H: Genetics and disease associations of human complement factor H

  2007cited by this paper
• Easy oxidation and nitration of human myoglobin by nitrite and hydrogen peroxide.

  2006cited by this paper
• A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.

  2005cited by this paper
• Complement Factor H Polymorphism in Age-Related Macular Degeneration

  2005cited by this paper
• [Complement factor H and macular degeneration].

  2005cited by this paper
• Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration

  2005cited by this paper
• IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis1

  2003cited by this paper
• Induction of angiogenic cytokine expression in cultured RPE by ingestion of oxidized photoreceptor outer segments.

  2003cited by this paper
• Age-related macular degeneration.

  2000cited by this paper
• Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells.

  1999cited by this paper
• An international classification and grading system for age-related maculopathy and age-related macular degeneration

  1995cited by this paper

• No citing papers are available for this paper.